TTF1 and non-small cell lung carcinoma: Awareness of the prevalence of TTF-1 negative NSCLC and the need for additional markers, such as SMARCA4 [76], to confirm a lung primary could increase the likelihood of this TOO being assigned to patients who may otherwise receive a diagnosis of CUP [10].